A controversial anti-malaria drug is being trialed as a therapy for COVID-19 at the B.C. seniors’ care home at the epicentre of the province’s novel coronavirus outbreak.
Global News has confirmed that residents of the Lynn Valley Care Centre are receiving hydroxychloroquine as a part of an international study on the effectiveness of the drug.
Forty-six residents and 24 staff at the facility have have tested positive for COVID-19. The drug is being administered to all residents of the virus-stricken building known as “the lodge” at the care home, with the exception of those who opted out of the trial.
Debra Drew, whose father is one of the COVID-19-positive residents of the facility, said her family decided to opt in. “As a family we had
Read more on globalnews.ca